Zkusit zdarma
Aura Biosciences, Inc.

Aura Biosciences, Inc.

AURA
Cena:
$ 7.60
-0.05 (-0.65%)
Valuace
70
Růst
0
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Aura Biosciences Highlights Bel-Sar Eye Cancer Strategy, Mid-Year Bladder Data

Aura Biosciences Highlights Bel-Sar Eye Cancer Strategy, Mid-Year Bladder Data

22:02 19-05-2026

Aura Biosciences NASDAQ: AURA executives outlined the company's strategy for its lead candidate bel-...

Aura Biosciences to Participate in Upcoming Investor Conferences

Aura Biosciences to Participate in Upcoming Investor Conferences

16:01 12-05-2026

BOSTON, May 12, 2026 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage bio...

Aura Biosciences Reports First Quarter 2026 Financial Results and Business Highlights

Aura Biosciences Reports First Quarter 2026 Financial Results and Business Highlights

16:01 11-05-2026

Phase 3 CoMpass trial advancing toward enrollment completion, supporting 2H 2027 topline data Natali...

AMG Reports Better than Expected First Quarter 2026 Results

AMG Reports Better than Expected First Quarter 2026 Results

12:00 06-05-2026

Amsterdam, 6 May 2026 (Regulated Information) --- AMG Critical Materials N.V. (“AMG”, EURONEXT A...

Aura Biosciences Announces Closing of $299 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares

Aura Biosciences Announces Closing of $299 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares

17:15 05-05-2026

BOSTON, May 05, 2026 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (“Aura”) (Nasdaq: AURA), a clini...

Aura Biosciences Announces Pricing of $260 Million Public Offering of Common Stock and Pre-funded Warrants

Aura Biosciences Announces Pricing of $260 Million Public Offering of Common Stock and Pre-funded Warrants

9:03 04-05-2026

BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (“Aura”) (Nasdaq: AURA), a clini...

Aura Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Aura Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

6:03 04-05-2026

BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. ("Aura") (Nasdaq: AURA), a clinical-...

Aura Biosciences Announces CEO Transition as Company Advances Phase 3 CoMpass Trial Toward Enrollment Completion

Aura Biosciences Announces CEO Transition as Company Advances Phase 3 CoMpass Trial Toward Enrollment Completion

6:01 04-05-2026

Natalie Holles, seasoned industry executive with significant rare disease operational and commercial...

Are Medical Stocks Lagging Aura Biosciences (AURA) This Year?

Are Medical Stocks Lagging Aura Biosciences (AURA) This Year?

10:42 22-04-2026

Here is how Aura Biosciences, Inc. (AURA) and Biodesix, Inc. (BDSX) have performed compared to their...

Does Aura Biosciences (AURA) Have the Potential to Rally 179.84% as Wall Street Analysts Expect?

Does Aura Biosciences (AURA) Have the Potential to Rally 179.84% as Wall Street Analysts Expect?

10:56 20-04-2026

The consensus price target hints at a 179.8% upside potential for Aura Biosciences (AURA). While emp...

Aura Biosciences, Inc. (AURA) Just Flashed Golden Cross Signal: Do You Buy?

Aura Biosciences, Inc. (AURA) Just Flashed Golden Cross Signal: Do You Buy?

10:56 10-04-2026

Aura Biosciences, Inc. (AURA) is looking like an interesting pick from a technical perspective, as t...

Is Aura Biosciences (AURA) Stock Outpacing Its Medical Peers This Year?

Is Aura Biosciences (AURA) Stock Outpacing Its Medical Peers This Year?

10:40 06-04-2026

Here is how Aura Biosciences, Inc. (AURA) and Biodesix, Inc. (BDSX) have performed compared to their...

Wall Street Analysts Predict a 201.49% Upside in Aura Biosciences (AURA): Here's What You Should Know

Wall Street Analysts Predict a 201.49% Upside in Aura Biosciences (AURA): Here's What You Should Know

10:56 02-04-2026

The mean of analysts' price targets for Aura Biosciences (AURA) points to a 201.5% upside in the sto...

Aura Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

Aura Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

7:00 30-03-2026

Accelerated Phase 3 CoMpass Enrollment Supports Mid-2026 Enrollment Completion and 2H 2027 Topline D...

Aura Biosciences, Inc. (NASDAQ:AURA) Given Average Rating of “Hold” by Brokerages

Aura Biosciences, Inc. (NASDAQ:AURA) Given Average Rating of “Hold” by Brokerages

4:32 27-03-2026

Shares of Aura Biosciences, Inc. (NASDAQ: AURA - Get Free Report) have been assigned an average rati...

Is Aura Biosciences (AURA) Outperforming Other Medical Stocks This Year?

Is Aura Biosciences (AURA) Outperforming Other Medical Stocks This Year?

10:40 20-03-2026

Here is how Aura Biosciences, Inc. (AURA) and Elicio Therapeutics (ELTX) have performed compared to ...

Aura Biosciences, Inc. (NASDAQ:AURA) Short Interest Update

Aura Biosciences, Inc. (NASDAQ:AURA) Short Interest Update

3:50 15-03-2026

Aura Biosciences, Inc. (NASDAQ: AURA - Get Free Report) was the target of a large drop in short inte...

Aura Biosciences Touts Phase 3 bel-sar Momentum, Eyes Mid-Year Bladder Cancer Data at TD Cowen Conference

Aura Biosciences Touts Phase 3 bel-sar Momentum, Eyes Mid-Year Bladder Cancer Data at TD Cowen Conference

1:32 05-03-2026

Aura Biosciences (NASDAQ: AURA) highlighted progress across its ocular oncology pipeline and provide...

What Makes Aura Biosciences (AURA) a New Buy Stock

What Makes Aura Biosciences (AURA) a New Buy Stock

13:01 13-02-2026

Aura Biosciences (AURA) might move higher on growing optimism about its earnings prospects, which is...

Permanent Capital Management LP Makes New Investment in Aura Biosciences, Inc. $AURA

Permanent Capital Management LP Makes New Investment in Aura Biosciences, Inc. $AURA

6:15 29-12-2025

Permanent Capital Management LP bought a new position in shares of Aura Biosciences, Inc. (NASDAQ: A...

close

AURA BIOSCIENCES TO PARTICIPATE IN THE 8TH ANNUAL EVERCORE HEALTHCARE CONFERENCE

24-11-2025
BOSTON, NOV. 24, 2025 (GLOBE NEWSWIRE) -- AURA BIOSCIENCES, INC. (NASDAQ: AURA), A CLINICAL-STAGE BI...
Více zde

AURA BIOSCIENCES REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

13-11-2025
AURA PROVIDES PHASE 3 COMPASS TRIAL COMPLETION GUIDANCE: 2026 ENROLLMENT COMPLETION AND Q4 2027 TOPL...
Více zde

INCENTIVE PROGRAM FOR THE CONVERSION OF BDRS INTO SHARES

02-10-2025
ROAD TOWN, BRITISH VIRGIN ISLANDS, OCT. 02, 2025 (GLOBE NEWSWIRE) -- AURA MINERALS INC. (NASDAQ: AU...
Více zde

WESTERN EXPLORATION FILES AMENDED NI 43-101 TECHNICAL REPORT FOR THE AURA GOLD SILVER PROJECT

01-10-2025
THERE IS NO IMPACT TO THE CAPITAL COSTS OR ECONOMIC RESULTS. THE ONLY CHANGE IS A SLIGHTLY REVISED A...
Více zde

AURA BIOSCIENCES TO PARTICIPATE IN THE H.C. WAINWRIGHT 27TH ANNUAL GLOBAL INVESTMENT CONFERENCE

03-09-2025
BOSTON, SEPT. 03, 2025 (GLOBE NEWSWIRE) -- AURA BIOSCIENCES, INC. (NASDAQ: AURA), A CLINICAL-STAGE ...
Více zde

AURA BIOSCIENCES REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

13-08-2025
CONTINUED CLINICAL PROGRAM EXECUTION IN THE PHASE 3 COMPASS TRIAL IN EARLY CHOROIDAL MELANOMA AND TH...
Více zde

AURA BIOSCIENCES ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK AND WARRANTS

15-05-2025
BOSTON, MAY 15, 2025 (GLOBE NEWSWIRE) -- AURA BIOSCIENCES, INC. (“AURA”) (NASDAQ: AURA), A CLINI...
Více zde

AURA BIOSCIENCES ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK AND WARRANTS

15-05-2025
BOSTON, MAY 15, 2025 (GLOBE NEWSWIRE) -- AURA BIOSCIENCES, INC. (“AURA”) (NASDAQ: AURA), A CLINI...
Více zde

AURA BIOSCIENCES REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

15-05-2025
FIRST PATIENT ENROLLED IN MULTI-DOSE PHASE 1B/2 TRIAL OF BEL-SAR IN NON-MUSCLE-INVASIVE BLADDER CANC...
Více zde

AURA BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

01-05-2025
BOSTON, MAY 01, 2025 (GLOBE NEWSWIRE) -- AURA BIOSCIENCES, INC. (NASDAQ: AURA), A CLINICAL-STAGE BI...
Více zde

AURA BIOSCIENCES ANNOUNCES APPOINTMENT OF TERESA BITETTI TO BOARD OF DIRECTORS

02-04-2025
BOSTON, APRIL 02, 2025 (GLOBE NEWSWIRE) -- AURA BIOSCIENCES, INC. (NASDAQ: AURA), A CLINICAL-STAGE B...
Více zde

AURA BIOSCIENCES REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

24-03-2025
POSITIVE PHASE 1 TRIAL DATA IN NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) PRESENTED AT THE 40TH ANNU...
Více zde

POSITIVE DATA FROM PHASE 1 TRIAL OF BEL-SAR IN PATIENTS WITH NON-MUSCLE-INVASIVE BLADDER CANCER (NMIBC) PRESENTED AT THE 40TH ANNUAL EUROPEAN ASSOCIATION OF UROLOGY CONGRESS

24-03-2025
CLINICAL COMPLETE RESPONSES OBSERVED WITH SINGLE LOW-DOSE OF BEL-SAR IN PATIENTS WITH INTERMEDIATE A...
Více zde

AURA BIOSCIENCES ANNOUNCES ADDITIONAL DATA FROM ONGOING PHASE 1 TRIAL IN NON-MUSCLE INVASIVE BLADDER CANCER TO BE PRESENTED AS A LATE-BREAKING ABSTRACT AT THE 40TH ANNUAL EUROPEAN ASSOCIATION OF UROLOGY CONGRESS

03-03-2025
AURA WILL PARTICIPATE IN THE RESEARCH FORUM AT THE 40TH ANNUAL EUROPEAN ASSOCIATION OF UROLOGY CONGR...
Více zde

AURA BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

25-02-2025
BOSTON, FEB. 25, 2025 (GLOBE NEWSWIRE) -- AURA BIOSCIENCES, INC. (NASDAQ: AURA), A CLINICAL-STAGE BI...
Více zde

MUSCLE INVASIVE BLADDER CANCER DRUG PIPELINE MARKET RESEARCH 2024 FEATURING AURA BIOSCIENCES, JANSSEN RESEARCH & DEVELOPMENT, ASIERIS PHARMACEUTICALS, AND REMEGEN

02-12-2024
THIS REPORT PROVIDES COMPREHENSIVE INSIGHTS ABOUT 10+ COMPANIES AND 10+ PIPELINE DRUGS IN MUSCLE INV...
Více zde

MULTIPLE CLINICAL COMPLETE RESPONSES DEMONSTRATED FOLLOWING SINGLE LOW DOSE ADMINISTRATION OF BEL-SAR IN PATIENTS WITH NON-MUSCLE-INVASIVE BLADDER CANCER (NMIBC) IN ONGOING PHASE 1 TRIAL

17-10-2024
CLINICAL COMPLETE RESPONSES OBSERVED IN 4 OUT OF 5 PATIENTS IN SUBSET OF PATIENTS WITH LOW GRADE DIS...
Více zde

AURA BIOSCIENCES REPORTS POSITIVE PHASE 2 END OF STUDY RESULTS EVALUATING BEL-SAR AS A FIRST-LINE TREATMENT FOR EARLY-STAGE CHOROIDAL MELANOMA

12-09-2024
BEL-SAR DEMONSTRATED 80% TUMOR CONTROL RATE, 90% VISUAL ACUITY PRESERVATION, AND A HIGHLY FAVORABLE ...
Více zde

AURA BIOSCIENCES TO HOST A UROLOGIC ONCOLOGY INVESTOR EVENT TO PRESENT EARLY NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) DATA FROM ITS ONGOING PHASE 1 TRIAL ON THURSDAY, OCTOBER 17, 2024

03-09-2024
SABINE DORIS BROOKMAN-MAY, MD, PHD TO JOIN AURA AS SENIOR VICE PRESIDENT, CLINICAL DEVELOPMENT UROLO...
Více zde

AURA BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

28-08-2024
BOSTON, AUG. 28, 2024 (GLOBE NEWSWIRE) -- AURA BIOSCIENCES, INC. (NASDAQ: AURA), A CLINICAL-STAGE B...
Více zde

AURA BIOSCIENCES ANNOUNCES THE PRESENTATION OF PHASE 2 END OF STUDY DATA EVALUATING SUPRACHOROIDAL ADMINISTRATION OF BEL-SAR FOR THE FIRST-LINE TREATMENT OF PATIENTS WITH EARLY-STAGE CHOROIDAL MELANOMA AT THE RETINA SOCIETY ANNUAL MEETING

26-08-2024
AURA WILL HOST A VIRTUAL OCULAR ONCOLOGY INVESTOR EVENT FEATURING KEY OPINION LEADERS AT 8:00 AM EAS...
Více zde

AURA BIOSCIENCES REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

08-08-2024
COMPANY TO PRESENT EARLY NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) DATA FROM ONGOING PHASE 1 TRIAL ...
Více zde

AURA BIOSCIENCES TO PARTICIPATE IN THE JEFFERIES GLOBAL HEALTHCARE CONFERENCE

30-05-2024
BOSTON, MAY 30, 2024 (GLOBE NEWSWIRE) -- AURA BIOSCIENCES, INC. (NASDAQ: AURA), A CLINICAL-STAGE BI...
Více zde

AURA BIOSCIENCES TO HOST VIRTUAL KOL EVENT “PIONEERING A NEW STANDARD OF CARE IN OCULAR ONCOLOGY” ON MAY 29, 2024

23-05-2024
BOSTON, MAY 23, 2024 (GLOBE NEWSWIRE) -- AURA BIOSCIENCES, INC. (NASDAQ: AURA), A CLINICAL-STAGE BIO...
Více zde

AURA BIOSCIENCES REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

09-05-2024
CONTINUED ENROLLMENT IN GLOBAL PHASE 3 COMPASS TRIAL IN SMALL CHOROIDAL MELANOMA AND INDETERMINATE L...
Více zde

AURA BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

08-05-2024
BOSTON, MAY 08, 2024 (GLOBE NEWSWIRE) -- AURA BIOSCIENCES, INC. (NASDAQ: AURA), A CLINICAL-STAGE BI...
Více zde

AURA BIOSCIENCES REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

27-03-2024
BOSTON--(BUSINESS WIRE)--AURA BIOSCIENCES, INC. (NASDAQ: AURA), A CLINICAL-STAGE BIOTECHNOLOGY COMPA...
Více zde

AURA BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

26-02-2024
BOSTON--(BUSINESS WIRE)--AURA BIOSCIENCES INC. (NASDAQ: AURA), A CLINICAL-STAGE BIOTECHNOLOGY COMPAN...
Více zde

AURA BIOSCIENCES ANNOUNCES FIRST PATIENT DOSED IN GLOBAL PHASE 3 COMPASS TRIAL EVALUATING THE SAFETY AND EFFICACY OF BELZUPACAP SAROTALOCAN (BEL-SAR) FOR FIRST-LINE TREATMENT OF EARLY-STAGE CHOROIDAL MELANOMA

07-12-2023
BOSTON--(BUSINESS WIRE)--AURA BIOSCIENCES INC. (NASDAQ: AURA), A CLINICAL-STAGE BIOTECHNOLOGY COMPAN...
Více zde

AURA BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

08-11-2023
BOSTON--(BUSINESS WIRE)--AURA BIOSCIENCES INC. (NASDAQ: AURA), A CLINICAL-STAGE BIOTECHNOLOGY COMPAN...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2025-11-13 00:00:008-KStáhnout
2025-11-13 00:00:0010-QStáhnout
2025-08-13 01:00:008-KStáhnout
2025-08-13 01:00:0010-QStáhnout
2025-08-13 00:00:008-KStáhnout
2025-08-13 00:00:0010-QStáhnout
2025-06-18 01:00:008-KStáhnout
2025-06-18 00:00:008-KStáhnout
2025-05-16 01:00:008-KStáhnout
2025-05-16 00:00:008-KStáhnout
2025-05-15 01:00:008-KStáhnout
2025-05-15 01:00:0010-QStáhnout
2025-05-15 00:00:008-KStáhnout
2025-05-15 00:00:0010-QStáhnout
2025-04-02 01:00:008-KStáhnout
2025-04-02 00:00:008-KStáhnout
2025-03-24 00:00:008-KStáhnout
2025-03-24 00:00:0010-KStáhnout
2025-03-23 23:00:008-KStáhnout
2025-03-23 23:00:0010-KStáhnout
2024-11-12 00:00:008-KStáhnout
2024-11-12 00:00:0010-QStáhnout
2024-11-11 23:00:008-KStáhnout
2024-11-11 23:00:0010-QStáhnout
2024-10-17 01:00:008-KStáhnout
2024-10-17 00:00:008-KStáhnout
2024-09-27 01:00:008-KStáhnout
2024-09-27 00:00:008-KStáhnout
2024-09-12 01:00:008-KStáhnout
2024-09-12 00:00:008-KStáhnout
2024-08-08 01:00:008-KStáhnout
2024-08-08 01:00:0010-QStáhnout
2024-08-08 00:00:008-KStáhnout
2024-08-08 00:00:0010-QStáhnout
2024-06-21 01:00:008-KStáhnout
2024-06-21 00:00:008-KStáhnout
2024-06-04 01:00:008-KStáhnout
2024-06-04 00:00:008-KStáhnout
2024-05-09 01:00:008-KStáhnout
2024-05-09 01:00:0010-QStáhnout
2024-05-09 00:00:008-KStáhnout
2024-05-09 00:00:0010-QStáhnout
2024-04-15 01:00:008-KStáhnout
2024-04-15 00:00:008-KStáhnout
2024-03-27 00:00:008-KStáhnout
2024-03-27 00:00:0010-KStáhnout
2024-03-26 23:00:008-KStáhnout
2024-03-26 23:00:0010-KStáhnout
2024-01-08 00:00:008-KStáhnout
2024-01-07 23:00:008-KStáhnout
2023-11-09 00:00:008-KStáhnout
2023-11-09 00:00:0010-QStáhnout
2023-11-08 23:00:008-KStáhnout
2023-11-08 23:00:0010-QStáhnout
2023-11-06 00:00:008-KStáhnout
2023-11-05 23:00:008-KStáhnout
2023-10-02 01:00:008-KStáhnout
2023-10-02 00:00:008-KStáhnout
2023-08-09 01:00:008-KStáhnout
2023-08-09 01:00:0010-QStáhnout
2023-08-09 00:00:008-KStáhnout
2023-08-09 00:00:0010-QStáhnout
2023-06-07 01:00:008-KStáhnout
2023-06-07 00:00:008-KStáhnout
2023-05-11 01:00:008-KStáhnout
2023-05-11 01:00:0010-QStáhnout
2023-05-11 00:00:008-KStáhnout
2023-05-11 00:00:0010-QStáhnout
2023-04-04 01:00:008-KStáhnout
2023-04-04 00:00:008-KStáhnout
2023-03-15 00:00:008-KStáhnout
2023-03-15 00:00:0010-KStáhnout
2023-03-14 23:00:008-KStáhnout
2023-03-14 23:00:0010-KStáhnout
2023-02-16 00:00:008-KStáhnout
2023-02-15 23:00:008-KStáhnout
2023-01-06 00:00:008-KStáhnout
2023-01-05 23:00:008-KStáhnout
2022-12-05 00:00:008-KStáhnout
2022-12-04 23:00:008-KStáhnout
2022-11-30 00:00:008-KStáhnout
2022-11-29 23:00:008-KStáhnout
2022-11-10 00:00:008-KStáhnout
2022-11-10 00:00:0010-QStáhnout
2022-11-09 23:00:008-KStáhnout
2022-11-09 23:00:0010-QStáhnout
2022-10-03 01:00:008-KStáhnout
2022-10-03 00:00:008-KStáhnout
2022-09-28 01:00:008-KStáhnout
2022-09-28 00:00:008-KStáhnout
2022-08-11 01:00:008-KStáhnout
2022-08-11 01:00:0010-QStáhnout
2022-08-11 00:00:008-KStáhnout
2022-08-11 00:00:0010-QStáhnout
2022-06-30 01:00:008-KStáhnout
2022-06-30 00:00:008-KStáhnout
2022-06-22 01:00:008-KStáhnout
2022-06-22 00:00:008-KStáhnout
2022-06-15 01:00:008-KStáhnout
2022-06-15 00:00:008-KStáhnout
2022-05-27 01:00:008-KStáhnout
2022-05-27 00:00:008-KStáhnout
2022-05-18 01:00:008-KStáhnout
2022-05-18 00:00:008-KStáhnout
2022-05-12 01:00:008-KStáhnout
2022-05-12 01:00:0010-QStáhnout
2022-05-12 00:00:008-KStáhnout
2022-05-12 00:00:0010-QStáhnout
2022-03-23 00:00:008-KStáhnout
2022-03-23 00:00:0010-KStáhnout
2022-03-22 23:00:008-KStáhnout
2022-03-22 23:00:0010-KStáhnout
2021-11-24 00:00:008-KStáhnout
2021-11-24 00:00:0010-QStáhnout
2021-11-23 23:00:008-KStáhnout
2021-11-23 23:00:0010-QStáhnout
2021-11-02 00:00:008-KStáhnout
2021-11-01 23:00:008-KStáhnout
preloader